IMMUNITYBIO, INC. Debt Conversion, Converted Instrument, Amount
IMMUNITYBIO, INC. (IBRX) reported Debt Conversion, Converted Instrument, Amount of $35.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-08-04
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-12-31 was $0.00.
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-09-30 was $0.00.
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-06-30 was $0.00.
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for fiscal 2024 was $188.54M, a 30.17% decline from fiscal 2023.
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for fiscal 2023 was $269.99M, a 419.74% increase from fiscal 2022.
- IMMUNITYBIO, INC. debt conversion, converted instrument, amount for fiscal 2022 was $51.95M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $35.33M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-23 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $188.54M 10-K · filed 2026-02-23 | |||
| 2023-12-31 | $269.99M 10-K · filed 2026-02-23 | |||
| 2022-12-31 | $51.95M 10-K · filed 2025-03-03 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-19 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $751.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $751.00K 10-Q · filed 2020-11-09 | $751.00K derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $751.00K 10-Q · filed 2020-08-07 | $751.00K derived: sum of 3 quarters · filed 2021-03-04 | $751.00K derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $751.00K 10-Q · filed 2020-05-11 | $751.00K derived: sum of 2 quarters · filed 2021-03-04 | $751.00K derived: sum of 3 quarters · filed 2021-03-04 | $751.00K derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-04 | $0.00 10-K · filed 2021-03-04 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-25 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $1.00M 10-K · filed 2017-03-15 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.00M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $1.00M 10-Q · filed 2015-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |